1. Home
  2. CINGW vs RNG Comparison

CINGW vs RNG Comparison

Compare CINGW & RNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • RNG
  • Stock Information
  • Founded
  • CINGW N/A
  • RNG 1999
  • Country
  • CINGW United States
  • RNG United States
  • Employees
  • CINGW 13
  • RNG N/A
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • RNG EDP Services
  • Sector
  • CINGW Health Care
  • RNG Technology
  • Exchange
  • CINGW Nasdaq
  • RNG Nasdaq
  • Market Cap
  • CINGW N/A
  • RNG N/A
  • IPO Year
  • CINGW 2021
  • RNG 2013
  • Fundamental
  • Price
  • CINGW $0.06
  • RNG $25.86
  • Analyst Decision
  • CINGW
  • RNG Buy
  • Analyst Count
  • CINGW 0
  • RNG 13
  • Target Price
  • CINGW N/A
  • RNG $37.69
  • AVG Volume (30 Days)
  • CINGW N/A
  • RNG 1.8M
  • Earning Date
  • CINGW N/A
  • RNG 05-06-2025
  • Dividend Yield
  • CINGW N/A
  • RNG N/A
  • EPS Growth
  • CINGW N/A
  • RNG N/A
  • EPS
  • CINGW N/A
  • RNG N/A
  • Revenue
  • CINGW N/A
  • RNG $2,400,395,000.00
  • Revenue This Year
  • CINGW N/A
  • RNG $6.11
  • Revenue Next Year
  • CINGW N/A
  • RNG $6.05
  • P/E Ratio
  • CINGW N/A
  • RNG N/A
  • Revenue Growth
  • CINGW N/A
  • RNG 8.99
  • 52 Week Low
  • CINGW N/A
  • RNG $23.89
  • 52 Week High
  • CINGW N/A
  • RNG $42.19
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • RNG 36.41
  • Support Level
  • CINGW N/A
  • RNG $23.89
  • Resistance Level
  • CINGW N/A
  • RNG $28.49
  • Average True Range (ATR)
  • CINGW 0.00
  • RNG 0.80
  • MACD
  • CINGW 0.00
  • RNG 0.04
  • Stochastic Oscillator
  • CINGW 0.00
  • RNG 42.83

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: